Driving forces for drug loading in drug carriers

Journal of Microencapsulation
Yang Li, Li Yang

Abstract

The loading capacity of a drug carrier is determined essentially by intermolecular interactions between drugs and carrier materials. In this review, the process of drug loading is described in detail based on the differences in the driving force for drug incorporation, including hydrophobic interaction, electrostatic interaction, hydrogen bonding, Pi-Pi stacking and van der Waals force. Modifying drug-loading sites of carrier materials with interacting groups aiming at tailoring drug-carrier interactions is reviewed by highlighting its importance for improving in vitro properties such as the loading capacity, release behaviour and stability. Other factors affecting drug loading, methods employed to predict the encapsulation capacity and the techniques to verify intermolecular interactions are also discussed to inform the readers of all-sided information on drug-loading processes and theories. The drug carriers can be designed more reasonably with the better understanding of the nature and interacting mechanism of intermolecular interactions.

References

Feb 1, 1990·Antimicrobial Agents and Chemotherapy·J BrajtburgG Medoff
Mar 1, 1990·Antimicrobial Agents and Chemotherapy·J BrajtburgG Medoff
Feb 1, 1995·Pharmaceutical Research·G S KwonK Kataoka
May 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J W Hiemenz, T J Walsh
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·M YokoyamaT Okano
Sep 2, 1999·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·M Jones, J Leroux
Jan 21, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·K KataokaG S Kwon
Jun 27, 2000·International Journal of Pharmaceutics·F A Alvarez-Núñez, S H Yalkowsky
Mar 27, 2001·Japanese Journal of Cancer Research : Gann·Y MizumuraT Kakizoe
Jun 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·A Harada, K Kataoka
Jun 12, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K J HarringtonJ S Stewart
Aug 31, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H GelderblomA Sparreboom
Feb 19, 2002·Current Opinion in Biotechnology·Warren C W ChanShuming Nie
Feb 21, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Afsaneh LavasanifarGlen S Kwon
Mar 19, 2002·Advanced Drug Delivery Reviews·Afsaneh LavasanifarGlen S Kwon
Aug 15, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yuji YamamotoKazunori Kataoka
Sep 5, 2002·Journal of the American Chemical Society·Mutasem Omar SinnokrotC David Sherrill
Sep 13, 2002·Biochimica Et Biophysica Acta·Sheela Ann AbrahamMarcel B Bally
Oct 8, 2003·Technology in Cancer Research & Treatment·Kenneth Lundstrom, Teni Boulikas
Jan 28, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jaeyoung LeeKilwon Cho
Apr 28, 2004·Advanced Drug Delivery Reviews·Anatoly N Lukyanov, Vladimir P Torchilin
Jun 16, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Vinayak P SantJean-Christophe Leroux
Aug 18, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Xintao ShuaiJinming Gao
Sep 14, 2004·Biomacromolecules·Dmitry V VolodkinGleb B Sukhorukov
Oct 20, 2004·Langmuir : the ACS Journal of Surfaces and Colloids·Eugenia Kharlampieva, Svetlana A Sukhishvili
Dec 9, 2004·Chemical Reviews·Odile Dechy-CabaretDidier Bourissou
Dec 14, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Kang Moo HuhKinam Park
Apr 2, 2005·Drug Delivery·I OrientiP G Montaldo
Nov 22, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jack W Singer
Feb 9, 2006·International Journal of Pharmaceutics·Ulf SiemoneitJosé Blanco-Méndez
Jun 22, 2006·Journal of the American Chemical Society·Francisco BalasMaría Vallet-Regí
Jul 11, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·Seung Rim YangJong-Duk Kim
Aug 5, 2006·Biochimica Et Biophysica Acta·Andreas FritzeRegine Peschka-Süss
Aug 23, 2006·Cancer Chemotherapy and Pharmacology·Scott A ShafferJack W Singer
Aug 24, 2006·Journal of Controlled Release : Official Journal of the Controlled Release Society·M Laird ForrestGlen S Kwon
Aug 26, 2006·Pharmaceutical Research·Patrick J MarsacLynne S Taylor
Nov 17, 2006·Pharmaceutical Research·V P Torchilin

❮ Previous
Next ❯

Citations

Aug 31, 2016·Pharmaceutical Development and Technology·Yang LiLi Yang
Mar 5, 2017·Colloids and Surfaces. B, Biointerfaces·You-Mei LiRen-Xi Zhuo
Jun 26, 2018·ChemistryOpen·Martina De VettaJuan J Nogueira
May 12, 2018·Journal of Physics. Condensed Matter : an Institute of Physics Journal·Bai-Zhuo LiGuang-Han Cao
May 19, 2020·ChemSusChem·Nasim Ghavidel, Pedram Fatehi
Jan 14, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Yaxin ZhengYingchun Zeng
May 22, 2020·The Journal of Pharmacy and Pharmacology·Ayat AbdelkaderMahmoud Elsabahy
Jun 17, 2021·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Yaxin ZhengYang Li
Aug 13, 2018·ACS Biomaterials Science & Engineering·Negar Hassani BesheliMehdi Farokhi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
L Lins, R Brasseur
Physical Review Letters
J R Manson, R H Ritchie
© 2022 Meta ULC. All rights reserved